CLINICAL PHARMACOKINETICS OF 5-METHYLTETRAHYDROHOMOFOLATE = PHARMACOCINETIQUE CLINIQUE DU 5-METHYLTETRAHYDROHOMOFOLATETI LI LOO; LIU HIUSHI; LU K et al.1983; CANCER RESEARCH; ISSN 0008-5472; USA; DA. 1983; VOL. 43; NO 2; PP. 921-924; ABS. ENG; BIBL. 11 REF.; GRAPH, FIGArticle

COMPARISON OF PLATINUM AND PLATINUM-IRIDIUM CATALYSTS FOR HEPTANE REFORMING AT DIFFERENT PRESSURESRICE RW; LU K.1982; J. CATAL.; ISSN 0021-9517; USA; DA. 1982; VOL. 77; NO 1; PP. 104-117; BIBL. 22 REF.Article

PHARMACOLOGY OF MITOXANTRONE IN CANCER PATIENTSNIRAMOL SAVARAJ; LU K; MANUEL V et al.1982; CANCER CHEMOTHER. PHARMACOL.; ISSN 0344-5704; DEU; DA. 1982; VOL. 8; NO 1; PP. 113-117; BIBL. 12 REF.Article

CLINICAL KINETICS OF 1,4-DIHYDROXY-5,8-BIS((2-(HYDROXYETHYLAMINO)ETHYL)AMINO)-9,10-ANTHRACE NEDIONESAVARAJ N; LU K; VALDIVIESO M et al.1982; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1982; VOL. 31; NO 3; PP. 312-316; BIBL. 10 REF.Article

DISPOSITION AND METABOLISM OF THIOPURINES. III: BETA -2'-DEOXYTHIOGUANOSINE AND 6-THIOGUANINE IN THE DOGTI LI LOO; LU K; BENVENUTO A et al.1981; CANCER CHEMOTHER. PHARMACOL.; ISSN 0344-5704; DEU; DA. 1981; VOL. 6; NO 2; PP. 131-136; BIBL. 11 REF.Article

PHARMACOLOGICAL DISPOSITION OF 1,4-BIS(2-((2-HYDROXYETHYL) AMINO) ETHYLAMINO)-9,10-ANTHRACENEDIONE DIACETATE IN THE DOGLU K; TI LI LOO.1980; CANCER RES.; USA; DA. 1980; VOL. 40; NO 5; PP. 1427-1430; BIBL. 8 REF.Article

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) OF THE NEW ANTINEOPLASTIC 9,10-ANTHRACENEDICARBOXALDEHYDE BIS ((4,5-DIHYDRO-1H-INIDAZOLE-2-YL) HYDRAZONE) DIHYDROCHLORIDE (CL 216,942; BISANTRENE)LU K; SAVARAJ N; HUANG MT et al.1982; J. LIQ. CHROMATOGR.; ISSN 0148-3919; USA; DA. 1982; VOL. 5; NO 7; PP. 1323-1328; BIBL. 3 REF.Article

SYNTHESES OF ¹⁴C-MUSTARD-LABELLED AND ¹⁴C-LEUCINE-LABELLED ASALEYFARQUHAR D; LU K; LOO TL et al.1980; J. LABELL. COMPOUNDS RADIOPHARM.; GBR; DA. 1980; VOL. 17; NO 2; PP. 159-170; BIBL. 7 REF.Article

THE PHARMACOLOGIC FATE OF THE ANTITUMOR AGENT 2-AMINO-1,3,4-THIADIAZOLE IN THE DOGLU K; TI LI LOO.1980; CANCER CHEMOTHER. PHARMACOL.; ISSN 0344-5704; DEU; DA. 1980; VOL. 4; NO 4; PP. 275-279; BIBL. 7 REF.Article

CLINICAL PHARMACOLOGICAL AND TOXICOLOGICAL STUDIES OF CIS-DIAMMINEDICHLOROPLATINUM (II) BY CONTINOUS INTRAVENOUS INFUSIONTI LI LOO; HALL SW; SALEM P et al.1978; BIOCHIMIE; FRA; DA. 1978; VOL. 60; NO 9; PP. 957-960; BIBL. 13 REF.Conference Paper

HIGH-PRESSURE LIQUID CHROMATOGRAPHIC ANALYSIS OF FTORAFUR AND ITS METABOLITES IN BIOLOGICAL FLUIDS.BENVENUTO JA; LU K; TILILOO et al.1977; J. CHROMATOGR.; NETHERL.; DA. 1977; VOL. 134; NO 1; PP. 219-222; BIBL. 6 REF.Article

CLINICAL PHARMACOKINETICS OF VINBLASTINE BY CONTINUOUS INTRAVENOUS INFUSION = PHARMACOCINETIQUE CLINIQUE DE LA VINBLASTINE PAR PERFUSION INTRAVEINEUSE CONTINUELU K; HWEE YONGYAP; TI LI LOO et al.1983; CANCER RESEARCH; ISSN 0008-5472; USA; DA. 1983; VOL. 43; NO 3; PP. 1405-1408; ABS. ENG; BIBL. 10 REF.; GRAPHArticle

PHARMACOKINETICS AND METABOLISM OF BETA -2'-DEOXYTHIOGUANOSINE AND 6-THIOGUANINE IN MANLU K; BENVENUTO JA; BODEY GP et al.1982; CANCER CHEMOTHER. PHARMACOL.; ISSN 0344-5704; DEU; DA. 1982; VOL. 8; NO 1; PP. 119-123; BIBL. 9 REF.Article

DICHLOROALLYL LAWSONEMCKELVEY EM; LOMEDICO M; LU K et al.1979; CLIN. PHARMACOL. THERAPEUT.; USA; DA. 1979; VOL. 25; NO 5 PART. 1; PP. 586-590; BIBL. 8 REF.Article

DISPOSITION AND METABOLISM OF 1-(TETRAHYDRO-2-FURANYL)-5-FLUOROURACIL (FTORAFUR) IN HUMANSBENVENUTO JA; LU K; HALL SW et al.1978; CANCER RES.; USA; DA. 1978; VOL. 38; NO 11; PP. 3867-3870; BIBL. 16 REF.Article

PHYSIOLOGICAL DISPOSITION OF 2,6-DIMETHYL-4-BENZYL-4-DEMETHYLRIFAMPICIN IN RATS, MICE, AND DOGS = LE SORT PHYSIOLOGIQUE DE LA DIMETHYL-2,6 BENZYL-4 DEMETHYL-4 RIFAMPICINE CHEZ LES RATS, LES SOURIS ET LES CHIENSWOLPERT MK; LU K; DERR CJ et al.1974; DRUG METABOL. DISPOSIT.; U.S.A.; DA. 1974; VOL. 2; NO 3; PP. 237-246; BIBL. 30REF.Article

Sintering of nanoceramicsLU, K.International materials reviews. 2008, Vol 53, Num 1, pp 21-38, issn 0950-6608, 18 p.Article

The thermal instability of nanocrystalline Ni-P materials with different grain sizesLU, K.Nanostructured materials. 1993, Vol 2, Num 6, pp 643-652, issn 0965-9773Article

Grain growth processes in nanocrystalline materials studied by differential scanning calorimetryLU, K.Scripta metallurgica et materialia. 1991, Vol 25, Num 9, pp 2047-2052, issn 0956-716XArticle

Nanocrystalline metals crystallized from amorphous solids : nanocrystallization, structure, and propertiesLU, K.Materials science & engineering. R, Reports. 1996, Vol 16, Num 4, pp 161-221, issn 0927-796XArticle

Seal glass for solid oxide fuel cellsMAHAPATRA, M. K; LU, K.Journal of power sources (Print). 2010, Vol 195, Num 21, pp 7129-7139, issn 0378-7753, 11 p.Article

Melting and superheating of crystalline solids : From bulk to nanocrystalsMEI, Q. S; LU, K.Progress in materials science. 2007, Vol 52, Num 8, pp 1175-1262, issn 0079-6425, 88 p.Article

An indirect approach to measure glass transition temperature in metallic glassesJIN, H. J; LU, K.International journal of materials research. 2006, Vol 97, Num 4, pp 388-394, issn 1862-5282, 7 p.Article

Identification of crystal nucleation and growth in an amorphous FeZr₂ alloy by means of electrical resistance measurementsLU, K; ZHANG, X. H.Philosophical magazine letters. 2000, Vol 80, Num 12, pp 797-805, issn 0950-0839Article

A two-relay differential protective scheme for Le-Blanc transformersLU, K.-C; NANMING CHEN.IEEE transactions on power delivery. 1999, Vol 14, Num 3, pp 857-862, issn 0885-8977Article